NCT07905274Not yet recruiting
Sarcopenia Risk in Obese T2DM Patients
Evaluation of Muscle Strength, Gait Speed, Sarcopenia Risk, and Associated Factors in Obese Patients With Type 2 Diabetes
Source: ClinicalTrials.gov · Last updated 29 Oct 2026
Brief summary (registry, in English)
This study aims to measure handgrip strength, walking speed, and the risk of muscle wasting in obese patients who have had diabetes for 5 years or longer, and to evaluate the relationship of these measures with factors that may influence them, such as the duration of diabetes, blood test results, body mass index, and the waist-to-height ratio.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 150 (estimated)
- First submitted
- 22 Oct 2026
- Start date
- 20 Oct 2026
- Primary completion date
- 20 Mar 2027
- Lead sponsor
- Bandırma Onyedi Eylül University
- Diseases
- Obesity, Type 2 diabetes
- NCT number
- NCT07905274
What you commit to
- Study type: Observational
- Planned participants: 150
- From 20 Oct 2026 to the primary completion date, 20 Mar 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Having undergone a major surgical procedure within the last 6 months.
- Having a diagnosis of malignancy and currently receiving oncological treatment.
Other illness
- Having type 1 diabetes mellitus or other specific types of diabetes.
- Having a neuromuscular disorder (such as stroke, paraplegia, tetraplegia, myopathy, muscular dystrophy, amyotrophic lateral sclerosis, Parkinson's disease, etc.) that could significantly affect muscle strength or walking performance.
- Being unable to complete the tests due to a lower-extremity amputation or an orthopedic condition.
- Having an acute infection or an acute systemic illness requiring hospitalization.
- Having a cognitive impairment or a psychiatric condition that hinders communication.
Other
- Pregnancy.
Who the study is looking for
- Being between 18 and 75 years of age.
- Having a diagnosis of Type 2 diabetes mellitus for ≥ 5 years.
- Having a BMI ≥ 30 kg/m².
- Being willing to participate in the study and providing written informed consent.
Age in the registry: 18 years to 75 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Bandırma Onyedi Eylul University Faculty of Medicine Coordinator of this site? Confirm its status | Bandırma | Turkey (Türkiye) | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.